Evaluation of administration and use of antihypertensive drugs in severe preeclampsia patients at X General Hospital in Jakarta
Abstract
The high number of maternal mortality rate (MMR) is still a problem in Indonesia. Three ethyologies of maternal death are infection (12%), hypertension in pregnancy (25%) and bleeding (30%). Pre-eclampsia as a form of hypertension during pregnancy requires antihypertensive drug therapy. Rationality assessment for any kinds of pharmacotherapy is based on the right indication, the right medicine, the right patient, and the right dose. The main indication for antihypertensive medication in pregnancy is applied to the mother’s in preventing cerebrovascular disease. The aim of this study was to evaluate the characteristics, patterns and accuracy of the administration and use of antihypertensive drugs in patients with severe preeclampsia at X General Hospital in Jakarta in 2018. It was a non-experimental study with a descriptive and retrospective design using medical records. Administration and use of antihypertensive drugs in patients with severe preeclampsia at the X General Hospital in Jakarta showed 91.9% right indication, 86.72% right drug, 96.9% right patient and only 5.26% right dose with 4.0% accuracy of rational administration and use of drugs. In conclusion, the right dose in the management of patients with severe preeclampsia in X General Hospital in Jakarta is still low. Further training and close monitoring and evaluation on the rational use of antihypertension in severe preeclampsia is needed.
References
Perkumpulan Obstetri dan Ginekologi Indonesia, Himpunan Kedokteran Feto Maternal. Pedoman Nasional Pelayanan Kedokteran, Diagnosis dan Tatalaksana Pre-Eklampsia, Kementerian Kesehatan Republik Indonesia, Jakarta. 2016
Angka Kematian Ibu, Bayi, dan Neonatal. Diunduh dari http://www.kesmas.kemkes.go.id/portal/konten/~rilis-berita/021517-di-rakesnas-2019_-dirjen-kesmas-paparkan-strategi-penurunan-aki-dan-neonatal 20 Juli 2019.
Queensland Clinical Guideline (QCG), Maternity and Neonatal Clinical Guideline Hypertension disorders of pregnancy, Queensland Clinical Guideline Steering Committee, Queensland. 2015.
Uzan, J., Carbonnel M, Piconne O, Asmar R, dan Ayoubi JM. Preeclampsia: Pathophysiology, Diagnosis and Management. Vascular Health and Risk Management, 7 : 467–474. 2011 July 19.
Sumampouw CM, Tendean H, Wagey F. Gambaran Preeklampsia Berat dan Eklampsia Ditinjau dari Faktor Risiko di RSUP Prof. Dr. R. D. Kandou Manado. Jurnal Medik Rehabilitasi (JMR). 2019
Kenny L, English F, McCarthy F. Risk Factors and Effective Management of Preeclampsia. Integrated Blood Pressure Control. 2015.
Sari TNV. Rasionalitas Penggunaan Obat Antihipertensi pada Pasien Preeklampsia di Instalasi Rawat Inap RSUD Dr.Moewardi Surakarta Periode 2016. Repository Universitas Setia Budi. 2018
Amri MU, Mutmainah N. Studi Penggunaan Obat Antihipertensi Pada Pasien Preeklampsia Berat di Instalasi Rawat Inap Rumah Sakit Daerah Dr.Moewardi Surakarta Tahun 2014. Fakultas Farmasi Universitas Muhamadiyah Surakarta, Surakarta. 2015.
Novianty, Tanzil S, Theodorus. Rasionalitas Penggunaan Antagonis Kalsium pada Wanita Hamil. Biomedical Journal of Indonesia. 2019.
Andriana DD, Dyah UE, Kurnia SN. Evaluasi Penggunaan Obat Antihipertensi pada Pasien Pre-Eklampsia Rawat Inap di RSUD Prof.Dr. Margono Soekarjo Purwokerto Periode Januari 2015-Juni 2016. Acta Pharmaciae Indonesia. 2018, 6 (1): 29-39.
Cox AG, Marshall SA, Palmer KR, Wallace EM. Current and emerging pharmacotherapy for emergency management of preeclampsia. Expert Opinion on Pharmacotherapy. 2019. DOI: 10.1080/14656566.2019.1570134.
Rana S, Lemoine E, Granger GP, Karumanchi SA. Preeclampsia Pathophysiology, Challenges, and Perspectives. Circ Res. 2019;124:1094-1112. DOI: 10.1161/CIRCRESAHA.118.313276.
